PBF-680, an oral A1 adenosine receptor antagonist, inhibits adenosine monophosphate (AMP) airway hyperresponsiveness (AHR) in mild-to-moderate asthma: a Phase-IIa proof-of-concept trial

EUROPEAN RESPIRATORY JOURNAL

EUROPEAN RESPIRATORY SOC JOURNALS LTD

1. Palobiofarma S. L., Spain